Evaluation of the effect of vitamin B6 on blood cells count in patients using linezolid

Phase 2

Recruiting

• Conditions: drug-induced pancytopenia.; Other drug-induced pancytopenia; D61.811

• Registration Number: IRCT20150721023282N13
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 September 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Manifestation with chronic osteomyelitis
Use of linezolid

Exclusion Criteria

Serum level of Hgb less than 8 g/dL
WBC count less than 4500 cells/mm3
Platelet count less than 50000 cells/mm3

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
White blood cell count. Timepoint: Before the intervention, the end of weeks 1, 2, and 3 of intervention. Method of measurement: Flow cytometry.;Serum level of hemoglobin. Timepoint: Before the intervention, the end of weeks 1, 2, and 3 of intervention. Method of measurement: Flow cytometry.;Blood platelet count. Timepoint: Before the intervention, the end of weeks 1, 2, and 3 of intervention. Method of measurement: Flow cytometry.